127
Supernus Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
117
FY23:
111
FY24:
172
FY25:
47.3
Change from FY21 to FY25
millions USD
FY21:
−81.9
FY22:
−217
FY23:
269
FY24:
−190
FY25:
4.11
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−10.5
FY23:
−398
FY24:
12.2
FY25:
9.13
millions USD
FY21:
−85.2
FY22:
−110
FY23:
−18.1
FY24:
−5.72
FY25:
60.6
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
116
FY23:
111
FY24:
171
FY25:
46.0
All amounts in millions USD